Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Cancer
Interventions: DRUG: capecitabine|DRUG: lapatinib ditosylate|OTHER: circulating tumor cell analysis|OTHER: laboratory biomarker analysis
Sponsor: UNICANCER